
Jeffrey T. Palenik
Examiner (ID: 10079, Phone: (571)270-1966 , Office: P/1615 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1615 |
| Total Applications | 1154 |
| Issued Applications | 622 |
| Pending Applications | 123 |
| Abandoned Applications | 453 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11031664
[patent_doc_number] => 20160228620
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-11
[patent_title] => 'SYSTEM FOR DELIVERY OF MEDICATION IN TREATMENT OF DISORDERS OF THE PELVIS'
[patent_app_type] => utility
[patent_app_number] => 15/131043
[patent_app_country] => US
[patent_app_date] => 2016-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 9272
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15131043
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/131043 | System for delivery of medication in treatment of disorders of the pelvis | Apr 17, 2016 | Issued |
Array
(
[id] => 11310307
[patent_doc_number] => 20160346417
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-01
[patent_title] => 'WATERLESS URINAL CAKE COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/096705
[patent_app_country] => US
[patent_app_date] => 2016-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5925
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15096705
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/096705 | WATERLESS URINAL CAKE COMPOSITIONS | Apr 11, 2016 | Abandoned |
Array
(
[id] => 13168147
[patent_doc_number] => 10100178
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-16
[patent_title] => Biopolymer blends as emulsion stabilizers
[patent_app_type] => utility
[patent_app_number] => 15/560254
[patent_app_country] => US
[patent_app_date] => 2016-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10357
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15560254
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/560254 | Biopolymer blends as emulsion stabilizers | Mar 28, 2016 | Issued |
Array
(
[id] => 15393763
[patent_doc_number] => 10537518
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-21
[patent_title] => Homogenization system of drugs into biodegradable polymer: smart polymer system
[patent_app_type] => utility
[patent_app_number] => 15/105465
[patent_app_country] => US
[patent_app_date] => 2016-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 23
[patent_no_of_words] => 13484
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15105465
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/105465 | Homogenization system of drugs into biodegradable polymer: smart polymer system | Mar 27, 2016 | Issued |
Array
(
[id] => 15468535
[patent_doc_number] => 10550130
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-04
[patent_title] => Benzo-thiazolo-imidazole compounds and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/071945
[patent_app_country] => US
[patent_app_date] => 2016-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 11551
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 363
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15071945
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/071945 | Benzo-thiazolo-imidazole compounds and uses thereof | Mar 15, 2016 | Issued |
Array
(
[id] => 11318466
[patent_doc_number] => 09517200
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-13
[patent_title] => 'Methods of delivering pharmaceutical agents'
[patent_app_type] => utility
[patent_app_number] => 15/069647
[patent_app_country] => US
[patent_app_date] => 2016-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 24
[patent_no_of_words] => 23845
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15069647
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/069647 | Methods of delivering pharmaceutical agents | Mar 13, 2016 | Issued |
Array
(
[id] => 11956243
[patent_doc_number] => 20170260393
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-14
[patent_title] => 'COMPOSITION COMPRISING ORGANOSILOXANE NANO LATEX AND PREPARATION OF ORGANOSILOXANE NANO LATEX'
[patent_app_type] => utility
[patent_app_number] => 15/066395
[patent_app_country] => US
[patent_app_date] => 2016-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7338
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15066395
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/066395 | Composition comprising organosiloxane nano latex and preparation of organosiloxane nano latex | Mar 9, 2016 | Issued |
Array
(
[id] => 10987548
[patent_doc_number] => 20160184493
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-30
[patent_title] => 'PARTIALLY ABSORBABLE FIBER-REINFORCED COMPOSITES FOR CONTROLLED DRUG DELIVERY'
[patent_app_type] => utility
[patent_app_number] => 15/064674
[patent_app_country] => US
[patent_app_date] => 2016-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5794
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15064674
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/064674 | PARTIALLY ABSORBABLE FIBER-REINFORCED COMPOSITES FOR CONTROLLED DRUG DELIVERY | Mar 8, 2016 | Abandoned |
Array
(
[id] => 13714063
[patent_doc_number] => 20170367986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-28
[patent_title] => CONTROLLED RELEASE FROM PARTICLES ENCAPSULATED BY MOLECULAR LAYER DEPOSITION
[patent_app_type] => utility
[patent_app_number] => 15/552122
[patent_app_country] => US
[patent_app_date] => 2016-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10055
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15552122
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/552122 | Controlled release from particles encapsulated by molecular layer deposition | Feb 24, 2016 | Issued |
Array
(
[id] => 10988954
[patent_doc_number] => 20160185899
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-30
[patent_title] => 'FUNCTIONALIZED POLYMER COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/047669
[patent_app_country] => US
[patent_app_date] => 2016-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 14797
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15047669
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/047669 | Functionalized polymer compositions | Feb 18, 2016 | Issued |
Array
(
[id] => 10812041
[patent_doc_number] => 20160158202
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-09
[patent_title] => 'Low Dose Pharmaceutical Composition'
[patent_app_type] => utility
[patent_app_number] => 15/047091
[patent_app_country] => US
[patent_app_date] => 2016-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10000
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15047091
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/047091 | Low Dose Pharmaceutical Composition | Feb 17, 2016 | Abandoned |
Array
(
[id] => 11684142
[patent_doc_number] => 09682174
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-20
[patent_title] => 'Multi-layer biodegradable device having adjustable drug release profile'
[patent_app_type] => utility
[patent_app_number] => 15/046285
[patent_app_country] => US
[patent_app_date] => 2016-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 28
[patent_no_of_words] => 13390
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 175
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15046285
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/046285 | Multi-layer biodegradable device having adjustable drug release profile | Feb 16, 2016 | Issued |
Array
(
[id] => 11249218
[patent_doc_number] => 09474702
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-10-25
[patent_title] => 'Cosmetic use of salicylic acid derivatives'
[patent_app_type] => utility
[patent_app_number] => 15/044189
[patent_app_country] => US
[patent_app_date] => 2016-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5891
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15044189
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/044189 | Cosmetic use of salicylic acid derivatives | Feb 15, 2016 | Issued |
Array
(
[id] => 11282483
[patent_doc_number] => 09498321
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-22
[patent_title] => 'Drug delivery device for peripheral artery disease'
[patent_app_type] => utility
[patent_app_number] => 15/042045
[patent_app_country] => US
[patent_app_date] => 2016-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8721
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15042045
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/042045 | Drug delivery device for peripheral artery disease | Feb 10, 2016 | Issued |
Array
(
[id] => 10812067
[patent_doc_number] => 20160158227
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-09
[patent_title] => 'TABLET COMPRISING 7-[4-(4-BENZO[B]THIOPHEN-4-YL-PIPERAZIN-1-YL)BUTOXY)-1H-QUINOLIN-2-ONE OR A SALT THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/019874
[patent_app_country] => US
[patent_app_date] => 2016-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7281
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15019874
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/019874 | TABLET COMPRISING 7-[4-(4-BENZO[B]THIOPHEN-4-YL-PIPERAZIN-1-YL)BUTOXY)-1H-QUINOLIN-2-ONE OR A SALT THEREOF | Feb 8, 2016 | Abandoned |
Array
(
[id] => 15604273
[patent_doc_number] => 10583177
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-10
[patent_title] => Formulations for oral administration of active agents
[patent_app_type] => utility
[patent_app_number] => 15/549436
[patent_app_country] => US
[patent_app_date] => 2016-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 13
[patent_no_of_words] => 31583
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15549436
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/549436 | Formulations for oral administration of active agents | Feb 8, 2016 | Issued |
Array
(
[id] => 11038724
[patent_doc_number] => 20160235679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-18
[patent_title] => 'HIGH SURFACE-AREA LYOPHILIZED COMPOSITIONS COMPRISING ARSENIC FOR ORAL ADMINISTRATION IN PATIENTS'
[patent_app_type] => utility
[patent_app_number] => 15/012355
[patent_app_country] => US
[patent_app_date] => 2016-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 25704
[patent_no_of_claims] => 104
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15012355
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/012355 | High surface-area lyophilized compositions comprising arsenic for oral administration in patients | Jan 31, 2016 | Issued |
Array
(
[id] => 15663803
[patent_doc_number] => 10596107
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-24
[patent_title] => Ophthalmic suspension composition
[patent_app_type] => utility
[patent_app_number] => 15/006525
[patent_app_country] => US
[patent_app_date] => 2016-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 42
[patent_no_of_words] => 10167
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15006525
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/006525 | Ophthalmic suspension composition | Jan 25, 2016 | Issued |
Array
(
[id] => 11348906
[patent_doc_number] => 20160367647
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-22
[patent_title] => 'TREATMENT OF OPHTHALMIC CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/004246
[patent_app_country] => US
[patent_app_date] => 2016-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11626
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15004246
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/004246 | Treatment of ophthalmic conditions | Jan 21, 2016 | Issued |
Array
(
[id] => 11348906
[patent_doc_number] => 20160367647
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-22
[patent_title] => 'TREATMENT OF OPHTHALMIC CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/004246
[patent_app_country] => US
[patent_app_date] => 2016-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11626
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15004246
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/004246 | Treatment of ophthalmic conditions | Jan 21, 2016 | Issued |